Immunotherapy With Nivolumab in Combination With Lenvatinib for Advanced Stage Hepatocellular Carcinoma
Clinical trial NCT03841201 · COMPLETED
Trial details
- NCT number
- NCT03841201
- Sponsor
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-12
- Primary completion
- 2022-10-27
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.